Jae Yoon Jeong
Overview
Explore the profile of Jae Yoon Jeong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mak L, Hoang J, Won Jun D, Chen C, Peng C, Yeh M, et al.
Hepatol Int
. 2021 Nov;
16(1):48-58.
PMID: 34822056
Background And Aims: We aimed to compare the longitudinal changes in estimated glomerular filtration rate (eGFR) in chronic hepatitis B (CHB) patients treated with entecavir (ETV) vs. tenofovir disoproxil fumarate...
12.
Tantai X, Liu Y, Yeo Y, Praktiknjo M, Mauro E, Hamaguchi Y, et al.
J Hepatol
. 2021 Nov;
76(3):588-599.
PMID: 34785325
Background & Aims: The association between sarcopenia and prognosis in patients with cirrhosis remains to be determined. In this study, we aimed to quantify the association between sarcopenia and the...
13.
Huang C, Jang T, Won Jun D, Ahn S, An J, Enomoto M, et al.
Liver Int
. 2021 Oct;
42(1):59-68.
PMID: 34687130
Background & Aims: Gamma-glutamyl transferase (GGT) has been predictive of chronic hepatitis C-related hepatocellular carcinoma (HCC) development. Its role in the risk of HCC in chronic hepatitis B (CHB) patients...
14.
Cho Y, Lee H, Jeong J, Lee J, Kim T, Nam S, et al.
J Comput Assist Tomogr
. 2021 Aug;
45(5):684-690.
PMID: 34407059
Objective: We evaluated the prognostic impacts of body composition components measured by computed tomography (CT) in patients with liver cirrhosis. Methods: A total of 160 cirrhotic patients who underwent CT...
15.
Park J, Le A, Tseng T, Yeh M, Won Jun D, Trinh H, et al.
Clin Gastroenterol Hepatol
. 2021 Jun;
20(4):874-885.e4.
PMID: 34089852
Background & Aims: Antiviral treatment criteria are based on disease progression risk, and hepatocellular carcinoma (HCC) surveillance recommendations for patients with chronic hepatitis B (CHB) without cirrhosis is based on...
16.
Liu M, Tseng T, Won Jun D, Yeh M, Trinh H, Wong G, et al.
Hepatol Int
. 2021 Jan;
15(1):71-81.
PMID: 33394321
Background: Increasing hepatitis-related mortality has reignited interest to fulfill the World Health Organization's goal of viral hepatitis elimination by 2030. However, economic barriers have enabled only 28% of countries to...
17.
Cho J, Jeong J, Sohn W
PLoS One
. 2020 Apr;
15(4):e0231485.
PMID: 32267895
This study aimed to investigate the risk of metabolic syndrome (MS) in participants whose alanine aminotransferase (ALT) levels were within the normal range in the general population. A cross-sectional study...
18.
Oh H, Yoon E, Won Jun D, Ahn S, Lee H, Jeong J, et al.
Clin Gastroenterol Hepatol
. 2020 Mar;
18(12):2793-2802.e6.
PMID: 32135246
Background & Aims: Studies to evaluate risks of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection treated with the nucelos(t)ide analogues entecavir or tenofovir have produced...
19.
Jeong J, Won Jun D, Park S, Sohn J, Kim S, Lee S, et al.
Korean J Intern Med
. 2019 Nov;
35(5):1074-1083.
PMID: 31710801
Background/aims: We aimed to assess the role of vitamin D supplementation in the response to pegylated interferon-α (PEG-IFN-α) plus ribavirin (RBV) treatment in patients with chronic hepatitis C (CHC). Methods:...
20.
Huang C, Iio E, Won Jun D, Ogawa E, Toyoda H, Hsu Y, et al.
Hepatol Int
. 2019 Aug;
13(5):587-598.
PMID: 31463665
Background And Aims: One-third of the global hepatitis C virus (HCV) burden is found in Asia. Real-world data from diverse East Asian cohorts remain limited. This study addressed the real-world...